| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 15 | 2025 | 614 | 1.280 |
Why?
|
| Proteome | 10 | 2024 | 287 | 1.000 |
Why?
|
| Protein Interaction Mapping | 6 | 2019 | 86 | 0.810 |
Why?
|
| Breast Neoplasms | 12 | 2024 | 2597 | 0.740 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2026 | 608 | 0.720 |
Why?
|
| Proteogenomics | 5 | 2025 | 111 | 0.690 |
Why?
|
| DNA Helicases | 4 | 2026 | 234 | 0.690 |
Why?
|
| Estrogen Receptor alpha | 7 | 2023 | 426 | 0.690 |
Why?
|
| Transcription Factors | 7 | 2026 | 2399 | 0.690 |
Why?
|
| Triple Negative Breast Neoplasms | 5 | 2025 | 280 | 0.650 |
Why?
|
| Cell Line, Tumor | 20 | 2026 | 3714 | 0.580 |
Why?
|
| Immunoprecipitation | 6 | 2019 | 189 | 0.550 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2025 | 1325 | 0.540 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2026 | 1001 | 0.530 |
Why?
|
| Mass Spectrometry | 7 | 2019 | 359 | 0.520 |
Why?
|
| Mice | 34 | 2026 | 18161 | 0.520 |
Why?
|
| Infertility, Male | 3 | 2024 | 296 | 0.480 |
Why?
|
| Algorithms | 6 | 2020 | 1662 | 0.480 |
Why?
|
| Peptides | 2 | 2020 | 704 | 0.470 |
Why?
|
| Nuclear Proteins | 5 | 2026 | 1208 | 0.470 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2026 | 815 | 0.470 |
Why?
|
| Animals | 42 | 2026 | 33656 | 0.460 |
Why?
|
| Cigarette Smoking | 2 | 2026 | 91 | 0.420 |
Why?
|
| Myeloproliferative Disorders | 2 | 2025 | 91 | 0.410 |
Why?
|
| Antineoplastic Agents | 4 | 2025 | 1800 | 0.410 |
Why?
|
| Multiprotein Complexes | 4 | 2013 | 195 | 0.410 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2026 | 2008 | 0.400 |
Why?
|
| Oocytes | 2 | 2026 | 282 | 0.400 |
Why?
|
| CRISPR-Cas Systems | 3 | 2024 | 316 | 0.370 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2015 | 318 | 0.370 |
Why?
|
| Proteins | 4 | 2024 | 1004 | 0.360 |
Why?
|
| Mitosis | 2 | 2025 | 191 | 0.350 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2026 | 598 | 0.350 |
Why?
|
| Transcription, Genetic | 7 | 2026 | 1363 | 0.340 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2026 | 479 | 0.340 |
Why?
|
| HeLa Cells | 8 | 2019 | 689 | 0.320 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2024 | 254 | 0.320 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2025 | 613 | 0.310 |
Why?
|
| Transcriptional Activation | 3 | 2018 | 418 | 0.310 |
Why?
|
| Ubiquitination | 5 | 2026 | 175 | 0.310 |
Why?
|
| Aging | 3 | 2026 | 1238 | 0.300 |
Why?
|
| Humans | 59 | 2026 | 130080 | 0.290 |
Why?
|
| Cysteine Endopeptidases | 1 | 2009 | 109 | 0.280 |
Why?
|
| Smoke | 2 | 2026 | 79 | 0.280 |
Why?
|
| Spermatozoa | 3 | 2025 | 254 | 0.280 |
Why?
|
| Response Elements | 4 | 2026 | 102 | 0.270 |
Why?
|
| Endometrial Neoplasms | 1 | 2009 | 108 | 0.270 |
Why?
|
| DNA-Activated Protein Kinase | 2 | 2026 | 27 | 0.260 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2023 | 287 | 0.260 |
Why?
|
| Proteolysis | 2 | 2025 | 199 | 0.260 |
Why?
|
| Protein Phosphatase 2 | 2 | 2025 | 34 | 0.250 |
Why?
|
| NEDD8 Protein | 1 | 2026 | 20 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2025 | 186 | 0.240 |
Why?
|
| Fatty Acid Synthase, Type I | 1 | 2026 | 15 | 0.240 |
Why?
|
| MDS1 and EVI1 Complex Locus Protein | 1 | 2025 | 3 | 0.240 |
Why?
|
| DNA | 4 | 2025 | 1398 | 0.240 |
Why?
|
| Blast Crisis | 1 | 2025 | 17 | 0.230 |
Why?
|
| Receptors, Progesterone | 2 | 2025 | 677 | 0.230 |
Why?
|
| Quinolones | 1 | 2025 | 58 | 0.230 |
Why?
|
| Sperm Maturation | 1 | 2025 | 15 | 0.230 |
Why?
|
| Axon Initial Segment | 1 | 2025 | 27 | 0.220 |
Why?
|
| Protein Binding | 8 | 2025 | 1649 | 0.220 |
Why?
|
| Estrogens | 4 | 2023 | 426 | 0.220 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2025 | 31 | 0.220 |
Why?
|
| Oogenesis | 1 | 2025 | 50 | 0.220 |
Why?
|
| Fibrosis | 2 | 2024 | 420 | 0.220 |
Why?
|
| Epididymis | 1 | 2025 | 62 | 0.220 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2026 | 104 | 0.220 |
Why?
|
| Sumoylation | 1 | 2025 | 47 | 0.220 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2025 | 82 | 0.220 |
Why?
|
| Skull | 1 | 2026 | 148 | 0.220 |
Why?
|
| CELF1 Protein | 1 | 2024 | 34 | 0.210 |
Why?
|
| Mice, Knockout | 8 | 2026 | 3810 | 0.210 |
Why?
|
| Female | 31 | 2026 | 70246 | 0.210 |
Why?
|
| Mice, Transgenic | 3 | 2025 | 2331 | 0.210 |
Why?
|
| Bone Marrow | 1 | 2026 | 317 | 0.210 |
Why?
|
| Ovarian Follicle | 1 | 2025 | 121 | 0.210 |
Why?
|
| Cellular Senescence | 1 | 2026 | 216 | 0.210 |
Why?
|
| Acetylcysteine | 1 | 2025 | 79 | 0.210 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2024 | 24 | 0.210 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2025 | 93 | 0.210 |
Why?
|
| Multigene Family | 1 | 2024 | 289 | 0.200 |
Why?
|
| Glycine | 1 | 2025 | 156 | 0.200 |
Why?
|
| Gene Rearrangement | 1 | 2025 | 322 | 0.200 |
Why?
|
| Small Molecule Libraries | 1 | 2025 | 130 | 0.200 |
Why?
|
| Ribosomes | 2 | 2022 | 123 | 0.200 |
Why?
|
| Fatty Acids | 1 | 2026 | 372 | 0.200 |
Why?
|
| Glutathione | 1 | 2025 | 200 | 0.200 |
Why?
|
| Receptors, Androgen | 1 | 2026 | 407 | 0.190 |
Why?
|
| Axons | 1 | 2025 | 382 | 0.190 |
Why?
|
| Peptide Hydrolases | 1 | 2023 | 131 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 8 | 2026 | 4691 | 0.180 |
Why?
|
| Prader-Willi Syndrome | 1 | 2023 | 62 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2023 | 583 | 0.180 |
Why?
|
| Host Cell Factor C1 | 1 | 2022 | 10 | 0.180 |
Why?
|
| Esomeprazole | 1 | 2022 | 33 | 0.180 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2026 | 325 | 0.180 |
Why?
|
| Homocystinuria | 1 | 2022 | 26 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2025 | 588 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 2 | 2015 | 253 | 0.170 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2022 | 43 | 0.170 |
Why?
|
| Repressor Proteins | 3 | 2022 | 756 | 0.170 |
Why?
|
| Oxidoreductases | 1 | 2022 | 105 | 0.170 |
Why?
|
| Heart Atria | 1 | 2024 | 340 | 0.170 |
Why?
|
| Genetic Techniques | 1 | 2021 | 95 | 0.170 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 168 | 0.170 |
Why?
|
| Apoptosis | 3 | 2025 | 1826 | 0.160 |
Why?
|
| Mitochondria | 1 | 2026 | 768 | 0.160 |
Why?
|
| Spliceosomes | 1 | 2021 | 47 | 0.160 |
Why?
|
| MCF-7 Cells | 5 | 2020 | 208 | 0.160 |
Why?
|
| Signal Transduction | 8 | 2025 | 4645 | 0.160 |
Why?
|
| Testis | 1 | 2022 | 389 | 0.160 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 115 | 0.160 |
Why?
|
| Unfolded Protein Response | 1 | 2020 | 66 | 0.160 |
Why?
|
| Carrier Proteins | 3 | 2023 | 996 | 0.160 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2020 | 15 | 0.160 |
Why?
|
| Chromatin | 3 | 2015 | 499 | 0.160 |
Why?
|
| RNA, Long Noncoding | 1 | 2023 | 219 | 0.160 |
Why?
|
| RNA, Messenger | 4 | 2019 | 2548 | 0.160 |
Why?
|
| Phosphorylation | 5 | 2025 | 1570 | 0.160 |
Why?
|
| Heart | 1 | 2025 | 659 | 0.160 |
Why?
|
| Stilbenes | 1 | 2020 | 34 | 0.160 |
Why?
|
| HIV-1 | 2 | 2015 | 492 | 0.160 |
Why?
|
| Nuclear Receptor Coactivator 3 | 4 | 2025 | 257 | 0.160 |
Why?
|
| Immunity | 1 | 2021 | 178 | 0.150 |
Why?
|
| Hormones | 1 | 2020 | 162 | 0.150 |
Why?
|
| Estrogen Antagonists | 1 | 2020 | 92 | 0.150 |
Why?
|
| Polyadenylation | 1 | 2020 | 47 | 0.150 |
Why?
|
| Biomarkers, Tumor | 2 | 2025 | 1580 | 0.150 |
Why?
|
| Trastuzumab | 1 | 2020 | 138 | 0.150 |
Why?
|
| Cell Cycle Proteins | 3 | 2026 | 705 | 0.150 |
Why?
|
| Protein Biosynthesis | 2 | 2022 | 570 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 1 | 2025 | 635 | 0.150 |
Why?
|
| Gene Expression Regulation | 6 | 2024 | 2322 | 0.140 |
Why?
|
| Claudins | 1 | 2018 | 29 | 0.140 |
Why?
|
| Cell Proliferation | 5 | 2026 | 2462 | 0.140 |
Why?
|
| Trophoblasts | 1 | 2019 | 113 | 0.140 |
Why?
|
| 3' Untranslated Regions | 1 | 2019 | 155 | 0.140 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 9 | 0.140 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 91 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 383 | 0.140 |
Why?
|
| 5' Untranslated Regions | 1 | 2018 | 58 | 0.140 |
Why?
|
| Genetic Markers | 1 | 2019 | 589 | 0.140 |
Why?
|
| Mutation | 4 | 2025 | 6064 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 68 | 0.130 |
Why?
|
| Genes | 1 | 2018 | 308 | 0.130 |
Why?
|
| Intestines | 1 | 2022 | 587 | 0.130 |
Why?
|
| Male | 17 | 2026 | 64385 | 0.130 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 316 | 0.130 |
Why?
|
| Drosophila | 1 | 2021 | 719 | 0.130 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 2891 | 0.130 |
Why?
|
| Pars Compacta | 1 | 2017 | 5 | 0.130 |
Why?
|
| Mice, SCID | 1 | 2018 | 583 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 521 | 0.130 |
Why?
|
| Trans-Activators | 4 | 2013 | 695 | 0.130 |
Why?
|
| Stem Cells | 1 | 2022 | 703 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 207 | 0.130 |
Why?
|
| Ventral Tegmental Area | 1 | 2017 | 48 | 0.130 |
Why?
|
| Brain | 2 | 2026 | 3145 | 0.120 |
Why?
|
| Atrial Fibrillation | 1 | 2024 | 736 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2019 | 405 | 0.120 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 10 | 0.120 |
Why?
|
| Models, Biological | 3 | 2023 | 1375 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2018 | 401 | 0.120 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2015 | 15 | 0.120 |
Why?
|
| Placenta | 1 | 2019 | 495 | 0.110 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 15 | 0.110 |
Why?
|
| Cell Movement | 1 | 2018 | 873 | 0.110 |
Why?
|
| Neurons | 2 | 2025 | 1978 | 0.110 |
Why?
|
| Karyopherins | 1 | 2015 | 35 | 0.110 |
Why?
|
| Protein Isoforms | 2 | 2026 | 422 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2025 | 238 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 662 | 0.100 |
Why?
|
| Nucleosomes | 1 | 2013 | 35 | 0.100 |
Why?
|
| Open Reading Frames | 2 | 2023 | 199 | 0.090 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 32 | 0.090 |
Why?
|
| Cyclin T | 1 | 2012 | 31 | 0.090 |
Why?
|
| Endometriosis | 1 | 2015 | 161 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2012 | 32 | 0.090 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 104 | 0.090 |
Why?
|
| Spermatogenesis | 2 | 2024 | 166 | 0.090 |
Why?
|
| Semen | 2 | 2023 | 84 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2015 | 502 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2019 | 883 | 0.090 |
Why?
|
| Chromatography, Liquid | 3 | 2023 | 233 | 0.090 |
Why?
|
| Fertility | 2 | 2024 | 260 | 0.090 |
Why?
|
| Software | 2 | 2013 | 733 | 0.090 |
Why?
|
| Homeostasis | 1 | 2015 | 712 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 716 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4639 | 0.080 |
Why?
|
| Glucose | 1 | 2015 | 851 | 0.080 |
Why?
|
| BRCA1 Protein | 1 | 2011 | 77 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 2392 | 0.080 |
Why?
|
| Neoplasms | 2 | 2023 | 2975 | 0.080 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 2 | 2025 | 82 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 360 | 0.080 |
Why?
|
| Databases, Protein | 3 | 2020 | 63 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2025 | 790 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 3464 | 0.080 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 15 | 0.080 |
Why?
|
| Histone Deacetylase 1 | 1 | 2010 | 20 | 0.080 |
Why?
|
| Oncogene Proteins | 2 | 2012 | 136 | 0.080 |
Why?
|
| Cell Line | 4 | 2019 | 2554 | 0.080 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2011 | 209 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2017 | 720 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2025 | 707 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 124 | 0.080 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2009 | 11 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 2107 | 0.070 |
Why?
|
| Solubility | 1 | 2009 | 117 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 94 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2009 | 212 | 0.070 |
Why?
|
| GPI-Linked Proteins | 1 | 2009 | 109 | 0.070 |
Why?
|
| Liver | 2 | 2012 | 1783 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 688 | 0.070 |
Why?
|
| Cell Survival | 2 | 2020 | 828 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2025 | 2885 | 0.070 |
Why?
|
| Biomarkers | 1 | 2017 | 3358 | 0.070 |
Why?
|
| Phenotype | 3 | 2023 | 4452 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2025 | 454 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2009 | 558 | 0.060 |
Why?
|
| Chick Embryo | 1 | 2026 | 121 | 0.060 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2026 | 85 | 0.060 |
Why?
|
| Sex Factors | 2 | 2025 | 1343 | 0.060 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2025 | 18 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2006 | 74 | 0.060 |
Why?
|
| Ligands | 2 | 2020 | 480 | 0.060 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2026 | 81 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 1 | 2026 | 141 | 0.060 |
Why?
|
| Autoantigens | 1 | 2006 | 97 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2006 | 129 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1931 | 0.060 |
Why?
|
| Transfection | 2 | 2019 | 961 | 0.060 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2024 | 9 | 0.060 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2025 | 37 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 265 | 0.050 |
Why?
|
| Quinolines | 1 | 2025 | 115 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2026 | 283 | 0.050 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 1025 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2017 | 317 | 0.050 |
Why?
|
| Imidazoles | 1 | 2025 | 219 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2025 | 222 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2026 | 310 | 0.050 |
Why?
|
| Protein Stability | 1 | 2024 | 164 | 0.050 |
Why?
|
| Nitriles | 1 | 2025 | 161 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2024 | 113 | 0.050 |
Why?
|
| Sperm Motility | 1 | 2024 | 113 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2025 | 137 | 0.050 |
Why?
|
| Estradiol | 2 | 2020 | 460 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1827 | 0.050 |
Why?
|
| Cellular Reprogramming | 1 | 2025 | 127 | 0.050 |
Why?
|
| Protein Interaction Maps | 1 | 2024 | 93 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2025 | 631 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2026 | 521 | 0.050 |
Why?
|
| Reproduction | 1 | 2024 | 210 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2023 | 106 | 0.050 |
Why?
|
| Purines | 1 | 2023 | 116 | 0.050 |
Why?
|
| Interferons | 1 | 2023 | 135 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2025 | 322 | 0.050 |
Why?
|
| DNA Repair | 1 | 2026 | 570 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 232 | 0.050 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2022 | 18 | 0.050 |
Why?
|
| Kidney | 1 | 2009 | 1279 | 0.050 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2022 | 32 | 0.050 |
Why?
|
| Antioxidants | 1 | 2025 | 331 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2025 | 354 | 0.050 |
Why?
|
| Histones | 1 | 2026 | 541 | 0.050 |
Why?
|
| Sterols | 1 | 2022 | 16 | 0.050 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2023 | 63 | 0.050 |
Why?
|
| Amidohydrolases | 1 | 2022 | 21 | 0.050 |
Why?
|
| Acyl Coenzyme A | 1 | 2022 | 23 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2022 | 19 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2025 | 355 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2024 | 766 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 59 | 0.040 |
Why?
|
| Ribosomal Proteins | 1 | 2022 | 70 | 0.040 |
Why?
|
| Receptors, Estrogen | 2 | 2020 | 728 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2024 | 329 | 0.040 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2021 | 87 | 0.040 |
Why?
|
| Cysteine | 1 | 2022 | 137 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2021 | 101 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 147 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2022 | 157 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 223 | 0.040 |
Why?
|
| Gentamicins | 1 | 2021 | 88 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2022 | 221 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2025 | 447 | 0.040 |
Why?
|
| Collagen | 1 | 2022 | 274 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2021 | 242 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 2020 | 31 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2026 | 755 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 56 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 94 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2021 | 291 | 0.040 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2020 | 32 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2020 | 144 | 0.040 |
Why?
|
| Transgenes | 1 | 2021 | 316 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2015 | 800 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 393 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2021 | 219 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2024 | 905 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2020 | 87 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 248 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 404 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 101 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 279 | 0.040 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2020 | 33 | 0.040 |
Why?
|
| Myocardium | 1 | 2025 | 859 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 282 | 0.040 |
Why?
|
| Disease Progression | 1 | 2026 | 2191 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 252 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 236 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 311 | 0.040 |
Why?
|
| Cholesterol | 1 | 2022 | 537 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2022 | 275 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2019 | 115 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2018 | 6 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 27 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 25 | 0.040 |
Why?
|
| Computational Biology | 2 | 2015 | 859 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 552 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 66 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 141 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Vimentin | 1 | 2018 | 59 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 131 | 0.040 |
Why?
|
| p21-Activated Kinases | 1 | 2018 | 57 | 0.030 |
Why?
|
| Triterpenes | 1 | 2018 | 22 | 0.030 |
Why?
|
| Protein Transport | 1 | 2019 | 365 | 0.030 |
Why?
|
| Benzofurans | 1 | 2018 | 33 | 0.030 |
Why?
|
| Heterografts | 1 | 2018 | 189 | 0.030 |
Why?
|
| Diet | 1 | 2025 | 1103 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2019 | 285 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 646 | 0.030 |
Why?
|
| RNA Helicases | 1 | 2018 | 73 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 378 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 428 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2022 | 951 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 699 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2017 | 90 | 0.030 |
Why?
|
| Homozygote | 1 | 2019 | 533 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1800 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2017 | 49 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2017 | 142 | 0.030 |
Why?
|
| Rats | 1 | 2023 | 3372 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1060 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 721 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 303 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 349 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 344 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1069 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 674 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2015 | 51 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1439 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 609 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1588 | 0.030 |
Why?
|
| Hippocampus | 1 | 2020 | 793 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 371 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 379 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 113 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 136 | 0.030 |
Why?
|
| Breast | 1 | 2015 | 213 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1674 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 43 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 64 | 0.020 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2013 | 50 | 0.020 |
Why?
|
| Cyclopentanes | 1 | 2013 | 21 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 83 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 99 | 0.020 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 95 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2015 | 499 | 0.020 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2012 | 4 | 0.020 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2012 | 16 | 0.020 |
Why?
|
| Endometrium | 1 | 2015 | 286 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2012 | 17 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 413 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 50 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 125 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 600 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2011 | 96 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 992 | 0.020 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2012 | 64 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 130 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2012 | 180 | 0.020 |
Why?
|
| Ubiquitinated Proteins | 1 | 2010 | 3 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 371 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 140 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 276 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 189 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2011 | 312 | 0.020 |
Why?
|
| Transcriptome | 1 | 2017 | 1097 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2010 | 44 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2010 | 83 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 1208 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2013 | 687 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6165 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 482 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 668 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 2729 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 491 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 1014 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 484 | 0.020 |
Why?
|
| Risk Factors | 1 | 2022 | 10960 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 1134 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7390 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 20821 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1453 | 0.020 |
Why?
|
| Cell Enlargement | 1 | 2006 | 6 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 9981 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 226 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 28314 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2005 | 158 | 0.010 |
Why?
|
| Antibodies | 1 | 2005 | 316 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 823 | 0.010 |
Why?
|
| Genome, Human | 1 | 2010 | 1318 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31011 | 0.010 |
Why?
|